Eman Badr: From Platelets to Precision Oncology
Eman Badr, Associate Professor of Zewail City of Science and Technology, shared a post on LinkedIn about a recent article she and her colleagues co-authored published in Discver Oncology, adding:
“A new paper from our group is now out in Discover Oncology:
‘Integrative analysis of tumor-educated platelets for stage-specific diagnosis, prognosis, and therapy in ovarian cancer’
In this study, we explored tumor-educated platelet mRNAs as a non-invasive source for ovarian cancer biomarker discovery.
We used an integrative computational framework that included differential expression analysis, machine learning, survival analysis, pathway enrichment, and in silico drug screening.
The study identified stage-specific candidate biomarkers and potential drug repurposing opportunities in ovarian cancer.
This work is special as it reflects the effort and persistence of my students, especially Shaimaa Gamal , who led this project as part of her MSc work, together with Mostafa Ibrahim.
I am very proud of them for their hard work, patience, and commitment throughout this journey.”
Title: Integrative analysis of tumor-educated platelets for stage-specific diagnosis, prognosis, and therapy in ovarian cancer
Authors: Shaimaa Gamal Gahin, Mostafa S. Ibrahim, Eman Badr

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 14:03Adil Aftab: Anticoagulation in CKD – Key Updates from the 2026 ESC Guidelines
-
Aug 31, 2026, 14:01Isa Oboirien: Why Might Factor XI Inhibition Work Differently in Stroke and ACS?
-
Aug 31, 2026, 13:55Mike Morrissey: Advancing Europe’s Cardiovascular Health Agenda at ESC Congress 2026
-
Aug 31, 2026, 13:44Penilla Gunther: Patient Voices Take Center Stage in Cardiovascular Prevention at ESC Congress 2026
-
Aug 31, 2026, 13:42Mohamed Saleh Gomaa: Master the Latest in PE Management
-
Aug 31, 2026, 13:38Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
-
Aug 31, 2026, 13:36Rafael Gomes: Can Prasugrel Replace Ticagrelor in ACS Treatment?
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients